English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 851604 Online Users : 928
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
生技與藥物研究所
徐祖安
--期刊論文
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
國家衛生研究院 NHRI
>
生技與藥物研究所
>
徐祖安
>
期刊論文
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Loading...
Siblings
會議論文/會議摘要
[
27
/39]
專利
[
0
/32]
Collection Statistics
近3年內發表的文件:8(5.56%)
含全文筆數:143(99.31%)
文件下載次數統計
下載大於0次:143(100.00%)
下載大於100次:141(98.60%)
檔案下載總次數:86887(84.49%)
最後更新時間: 2024-11-28 14:15
Top Upload
Loading...
Top Download
Loading...
Recent Submissions
Development of a humanized antibody...
Reducing brain Abeta burden amelior...
Development of furanopyrimidine-bas...
Targeting the phosphatidylserine-im...
Synthesis and evaluation of small m...
Extracellular HSP90alpha induces My...
The beneficial effects of combining...
Acyl-coenzyme a synthetase long-cha...
Colloidal assemblies composed of po...
The effects of Abeta1-42 binding to...
Jump to a point in the index:
(Choose year)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(Choose month)
January
February
March
April
May
June
July
August
September
October
November
December
Or type in a year:
Ordering With Most Recent First
Show Oldest First
Showing items 1-25 of 144. (6 Page(s) Totally)
1
2
3
4
5
6
>
>>
View [
10
|
25
|
50
] records per page
Date
Title
Relation
2024-07-04
Development of a humanized antibody targeting extracellular HSP90alpha to suppress endothelial-mesenchymal transition-enhanced tumor growth of pancreatic adenocarcinoma cells
Cells. 2024 Jul 04;13(13):Article number 1146.
2024-04
Reducing brain Abeta burden ameliorates high-fat diet-induced fatty liver disease in APP/PS1 mice
Biomedicine and Pharmacotherapy. 2024 Apr;173:Article number 116404.
2023-02-07
Development of furanopyrimidine-based orally active third-generation EGFR inhibitors for the treatment of non-small cell lung cancer
Journal of Medicinal Chemistry. 2023 Feb 7;66(4):2566-2588.
2022-10-13
Targeting the phosphatidylserine-immune checkpoint with a small-molecule maytansinoid conjugate
Journal of Medicinal Chemistry. 2022 Oct 13;65(19):12802-12824.
2022-06-21
Synthesis and evaluation of small molecule drug conjugates harnessing thioester-linked maytansinoids
Pharmaceutics. 2022 Jun 21;14(7):Article number 1316.
2022-01-18
Acyl-coenzyme a synthetase long-chain family member 4 is involved in viral replication organelle formation and facilitates virus replication via ferroptosis
mBio. 2022 Jan 18;13(1):Article number e0271721.
2022-01-11
Extracellular HSP90alpha induces MyD88-IRAK complex-associated IKKalpha/Beta−NF-KappaB/IRF3 and JAK2/TYK2−STAT-3 signaling in macrophages for tumor-promoting M2-polarization
Cells. 2022 Jan 11;11(2):Article number 229.
2022-01-05
The beneficial effects of combining anti-Abeta antibody NP106 and curcumin analog TML-6 on the treatment of Alzheimer’s disease in APP/PS1 mice
International Journal of Molecular Sciences. 2022 Jan 5;23(1):Article number 556.
2021-07-30
The effects of Abeta1-42 binding to the SARS-CoV-2 spike protein S1 subunit and angiotensin-converting enzyme 2
International Journal of Molecular Sciences. 2021 Jul 30;22(15):Article number 8226.
2021-07-16
Colloidal assemblies composed of polymeric micellar/emulsified systems integrate cancer therapy combining a tumor-associated antigen vaccine and chemotherapeutic regimens
Nanomaterials. 2021 Jul 16;11(7):Article number 1844.
2021-01
Effect of a neuropilin-1-derived virus receptor trap on enterovirus A71 infection in vitro
Antimicrobial Agents and Chemotherapy. 2021 Jan;65(1):Article number e00695-20.
2020-12
Engineering a novel IgG-like bispecific antibody against enterovirus A71
Biochemistry and Biophysics Reports. 2020 Dec;24:Article number 100860.
2020-08-20
Discovery of M protease inhibitors encoded by SARS-CoV-2
Antimicrobial Agents and Chemotherapy. 2020 Aug 20;64(9):e00872-20.
2020-08
Artificial intelligence approach fighting COVID-19 with repurposing drugs
Biomedical Journal. 2020 Aug;43(4):355-362.
2020-08
Repurposing old drugs as antiviral agents for coronaviruses
Biomedical Journal. 2020 Aug;43(4):368-374.
2020-06-02
Zika virus NS3 protease pharmacophore anchor model and drug discovery
Scientific Reports. 2020 Jun 2;10:Article number 8929.
2020-05
Antiviral activity of llama-inspired single domain antibody against Enterovirus A71
Antimicrobial Agents and Chemotherapy. 2020 May;64(5):Article number e01922-19.
2020-05
Drug-like property optimization: Discovery of orally bioavailable quinazoline-based multi-targeted kinase inhibitors
Bioorganic Chemistry. 2020 May;98:Article number 103689.
2020-04
BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine
Neuropharmacology. 2020 Apr;166:Article number 107678.
2019-11-27
Discovery of a furanopyrimidine-based epidermal growth factor receptor inhibitor (DBPR112) as a clinical candidate for the treatment of non-small cell lung cancer
Journal of Medicinal Chemistry. 2019 Nov 27;62(22):10108-10123.
2019-07-11
Linker optimization and therapeutic evaluation of phosphatidylserine-targeting zinc dipicolylamine-based drug conjugates
Journal of Medicinal Chemistry. 2019 Jul 11;62(13):6047-6062.
2019-05-28
Identification of novel anti-liver cancer small molecules with better therapeutic index than sorafenib via zebrafish drug screening platform
Cancers. 2019 May 28;11(6):Article number 739.
2019-04-01
A novel, potent, and orally bioavailable thiazole HCV NS5A inhibitor for the treatment of hepatitis C virus
European Journal of Medicinal Chemistry. 2019 Apr 1;167:245-268.
2019-02-20
Convallatoxin enhance the ligand-induced mu-opioid receptor endocytosis and attenuate morphine antinociceptive tolerance in mice
Scientific Reports. 2019 Feb 20;9:Article number 2405.
2018-10
Identification of novel Cdc7 kinase inhibitors as anti-cancer agents that target the interaction with Dbf4 by the fragment complementation and drug repositioning approach
EBioMedicine. 2018 Oct;36:241-251.
Showing items 1-25 of 144. (6 Page(s) Totally)
1
2
3
4
5
6
>
>>
View [
10
|
25
|
50
] records per page
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback